According to news on February 5, according to the Ministry of National Defense website, on February 4, China conducted a land-based mid-range anti-missile interception technology test within its territory, and the test achieved its expected purpose. This test is defensive and does not target any country.

News on February 2 According to the Financial Associated Press, it was learned from people familiar with the matter that BYD’s “blade battery” has been designated by Hyundai Motor Group and a Hyundai project team has been established. It is expected to start supplying overseas next year. In this regard, BYD’s secretary of the board said, “Does not rule out the possibility of cooperation with the modern future.”

In March last year, BYD officially released the blade battery to the outside world, and in July released BYD's new energy flagship sedan Han, the first blade battery.

BYD Chairman Wang Chuanfu said that the BYD blade battery is based on BYD lithium iron phosphate technology, and its volumetric energy density is the same as that of mainstream ternary lithium batteries. The power stored in the same volume is almost the same, but the safety is far more than that of ternary lithium batteries. .

BYD will supply "blade batteries" to FAW and Hongqi, and install them in the second half of the year.

Recently, Huawei Technologies Co., Ltd. has added a number of trademark application information. The trademarks include "petal search", "petal map", "petal", etc. The international classification involves scientific instruments, transportation and storage, etc.

Among them, the international classification of "petal search" is classified into 35 types of advertising sales, "petal map" is classified as 39 types of transportation and storage, and "petal" is classified into 44 types of medical gardening.

All three trademarks were applied for on the same day on January 6, and the status of the trademarks was "application for registration".

Not long ago, Huawei Technologies Co., Ltd. added a number of chip-related trademark application information, including "Lingxi Chip" and "Lingxi Processor". The international classification involves scientific instruments, and the trademark status is "application for registration".

On January 9, Beijing time, the State Council’s Joint Prevention and Control Mechanism held a press conference. Zeng Yixin, deputy director of the National Health Commission, said that so far, my country has carried out nearly 9 million doses of new coronavirus vaccination, proving that my country's new coronavirus vaccine has good safety. In the next step, we will comprehensively and orderly promote the vaccination of high-transmission groups, high-risk groups and the general population, and implement free vaccination for all. Li Tao, deputy director of the National Medical Security Administration, said that the cost of vaccination will be borne by the medical insurance fund and finance, and residents will not bear the cost.

Sinopharm China Biosciences has started the large-scale production of the new crown vaccine. Each dose of vaccine has an electronic ID card that traces the flow of the vaccine throughout. Where the vaccine reaches and who is vaccinated will be recorded.

It is understood that the new crown vaccine packaging is divided into light inspection, rotary rod labeling, boxing, weighing, and coding systems to ensure the quality and safety of the vaccine.

Yang Xiaoming, Chairman of Sinopharm Group China Biotechnology, introduced that the regulatory code is equivalent to the "electronic ID card" of vaccines, which is divided into three levels: each vaccine is individually coded, every 10 vaccines is composed of a medium package code, and contains multiple medium packages The large package and then code.

Through the supervision code, you can check whether the vaccine production, warehousing, storage, delivery, transportation and other processes meet the standards, and track the person receiving the injection.

The size of my country's new crown vaccine market may be nearly 100 billion

China Securities Investment said that at this stage, orders for the new crown vaccine have been placed. According to the order volume, the country’s penetration rate is calculated. The United States, the United Kingdom, the European Union of four countries and Japan are respectively 100%, 100%, 65% and 100%. Taking into account the epidemic situation in my country Stable, but the world is still in the pandemic stage and my country is accompanied by repeated regional epidemics. It is estimated that the penetration rate of my country's new crown vaccine is generally assumed to be 60%, and the corresponding market size is about 84 billion yuan.

According to the agency, according to my country’s current clinical trial phase of the new crown vaccine project, according to the existing design capacity limit is about 1.8 billion doses, which can meet the demand of 900 million people. Considering the time required for the release of production capacity of some enterprises, it will be available in a short time. There are still gaps in the supply of new crown vaccine projects to the domestic and developing markets.